Merit Medical Systems, Inc. (MMSI) is a leading global manufacturer and distributor of disposable medical devices used in interventional, diagnostic, and therapeutic medical procedures, primarily in the fields of cardiology, radiology, and endoscopy. The company was established in 1957 and has its headquarters in South Jordan, Utah.
MMSI offers a comprehensive portfolio of high-performance products for different medical fields. These products include inflation devices, catheter guide wires, microcatheters, drainage catheters, embolotherapy products, angioplasty balloons, stent delivery systems, and more. MMSI's products are designed to provide physicians with precise and effective tools to treat a wide array of medical conditions.
The company operates through two business segments: Cardiovascular and Endoscopy. The cardiovascular segment offers cardiology and radiology devices for diagnosing and treating coronary arterial disease, peripheral vascular disease, and other cardiovascular-related diseases. The endoscopy segment offers various devices for diagnosing and treating gastrointestinal conditions, pulmonary conditions, and other diseases.
As a globally reputed medical devices provider, MMSI serves hospitals, clinics, and medical facilities in over 60 countries worldwide. Firmly established in the US, the company has expanded its marketing network into several continental regions, including Europe, Asia, the Middle East, and Africa. MMSI also maintains several manufacturing facilities overseas, which helps cater to the ever-growing demand and meet international quality standards effectively.
MMSI continually invests in developing innovative and advanced products. The company's focus on research and development has resulted in a rich line of patented technologies, which has subsequently led to enhanced product offerings. This ability to design, engineer, and manufacture complex devices sets MMSI apart from many of its industrial peers.
Despite the highly competitive industry environment, MMSI has managed to maintain steady growth. This can partly be attributed to its effective customer-focused strategies and its commitment to delivering high-quality, cutting-edge medical devices. MMSI's strong financial performance reflects its resilience and adaptability in changing market conditions.
In a nutshell, Merit Medical Systems, Inc. continues to build upon its strong foundation and leadership in the medical device industry. With its consistent focus on innovation, its wide range of product offerings, and its dedication to superior quality, MMSI is well-positioned for long-term success.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Merit Medical Systems, Inc. (MMSI), a healthcare sector player with a $5.1 billion market cap, shows strong operational performance with 9.50% revenue growth and an EPS of 2.43. Analysts are largely positive, with a consensus target price of $101.45, suggesting an 18.84% upside. The company's focus on reinvesting earnings for growth, coupled with its global presence and diversified product portfolio, makes it an attractive opportunity for growth-oriented investors.
Merit Medical Systems, Inc. announced its participation in several investor conferences in September 2026. Management will attend the Wells Fargo 2026 Healthcare Conference, the Baird 2026 Global Healthcare Conference, the 19th Annual Barrington Research Virtual Fall Investment Conference, and the Sidoti Small Cap Conference. Live audio webcasts and replays of relevant sessions will be available on the company's investor relations website.
_07_03_2026_03_50_21_133108.jpg)
Merit Medical Systems (NASDAQ: MMSI) has appointed Lewis Sheri as Executive Vice President of Global Operations. This appointment also includes Sheri's initial insider stake in the company, as confirmed by a recent Form 3 filing. This move introduces a new senior operational leader to the company's global operations.
Stock Traders Daily provides a technical analysis of Merit Medical Systems Inc. (NASDAQ: MMSI), indicating neutral readings in shorter horizons and potential easing of a long-term weak bias. The analysis includes AI-generated trading strategies for different risk profiles, along with multi-timeframe signal analysis detailing support and resistance levels.
Merit Medical Systems (MMSI) has appointed Sheri Lewis as Executive Vice President of Global Operations, a change that could impact the company's efficiency, cost management, and resilience. Despite the company's recent strong share price performance and trading at a discount to fair value estimates, investors are considering potential risks like reimbursement delays and higher operating costs. The market currently views MMSI as 9.6% undervalued, with a fair value of $100.27 driven by expectations of improved margins and cash flow.
Merit Medical Systems' COO, Neil Peterson, sold 7,500 shares of MMSI for approximately $678,375. This transaction is part of a broader trend of insider selling at the company over the past year, with 33,949 shares sold and no purchases by Peterson. The stock is currently trading near its intrinsic value based on GuruFocus's GF Value, suggesting it is fairly valued.
Merit Medical Systems Inc.'s COO, Neil W. Peterson, sold 7,500 common stock shares on August 24, 2026, at an average price of $90.448 per share. Following this transaction, Peterson directly holds 18,051 common stock shares and also possesses significant non-qualified stock options. The sale details were disclosed in a Form 4 filed on August 25, 2026.